TrialMolecular oncology2025

Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.

Susanne Klein-Scory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.